以癫痫起病的IDH野生型胶质母细胞瘤伴突触特征上调
本研究在363例胶质瘤中评估癫痫起病频率,IDH野生型胶质母细胞瘤(GBM)的癫痫起病率显著低于IDH突变型星形细胞瘤和少突胶质细胞瘤;在IDH野生型GBM中,癫痫起病与更小肿瘤体积及更少瘤周水肿相关,转录层面表现为离子转运与突触功能通路上调。
要点
- IDH野生型GBM癫痫起病率30.5%,低于IDH突变型星形细胞瘤56.6%与少突胶质细胞瘤66.7%(p < 0.001)。
- IDH野生型GBM中癫痫起病与更小肿瘤体积和更少瘤周水肿相关(均p < 0.001)。
- SLC17A8(VGLUT3)表达对IDH野生型GBM癫痫起病具独立预测价值(p = 0.019,OR 3.44)。
核心结论
- 在IDH野生型GBM中,以癫痫起病的肿瘤体积更小,转录上伴突触与离子通路上调,SLC17A8具独立预测价值。
- 各胶质瘤亚型中,起病时癫痫与复发时癫痫之间未见生存差异。
研究设计与样本
- 单中心队列研究,纳入363例胶质瘤:190例IDH野生型GBM、113例IDH突变型星形细胞瘤、60例IDH突变型少突胶质细胞瘤。
- 采用多因素Cox回归进行生存分析,并对部分患者行bulk RNA测序及多因素logistic回归分析癫痫起病。
主要发现
- IDH野生型GBM癫痫起病率30.5%,IDH突变型星形细胞瘤56.6%,IDH突变型少突胶质细胞瘤66.7%(p < 0.001),各组复发时癫痫无差异。
- IDH野生型GBM中癫痫起病与更小肿瘤体积及更少瘤周水肿相关(均p < 0.001);IDH突变型星形细胞瘤中与更小肿瘤体积(p = 0.0289)及更低级别(p = 0.026)相关。
- 癫痫起病的IDH野生型肿瘤中离子转运与突触功能通路上调,包括IGFN1、RELN和SLC17A8(VGLUT3),VGLUT3蛋白水平升高。
关键数值与推荐
- 多因素logistic回归:颞叶位置p = 0.032(OR 3.25)、顶叶位置p = 0.023(OR 5.44)、SLC17A8水平p = 0.019(OR 3.44)为正预测因素。
- 水肿存在p = 0.004(OR -7.57)与ADAMTS2表达p = 0.015(OR -3.46)为负预测因素。
临床怎么用
- 对IDH野生型GBM患者,癫痫起病提示肿瘤体积较小、瘤周水肿较少,可结合位置与分子特征评估癫痫风险。
- SLC17A8(VGLUT3)可作为IDH野生型GBM癫痫起病的候选生物标志物,供进一步验证。
局限性
- 转录分析仅基于队列中部分患者的bulk RNA测序数据。
- 为单中心回顾性队列,预测模型需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Epileptic activity is common throughout the glioma disease course and causes significant morbidity for patients. While its clinical impact on glioma has been analyzed, the underlying biological mechanisms of hyperactivity remain uncharacterized. Herein, the authors characterized the differences in epileptic activity across the disease course of various glioma subtypes based on tumor grade and histopathology. To gain further understanding of potential transcriptional differences between tumor cases presenting with seizures and those with other presentation signs, they analyzed a subset of patients with bulk RNA-sequenced tumors. METHODS: The authors assessed clinical factors associated with glioma-related epilepsy across gliomas: IDH-wildtype glioblastoma (GBM), IDH-mutant astrocytoma, and IDH-mutant oligodendroglioma. They conducted multivariate Cox regression for survival analysis, incorporating variables known to influence glioma patient survival and seizure status. They also utilized bulk RNA sequencing to assess transcriptional correlates of hyperactivity in a subset of the cohort and conducted multivariate logistic regression for seizure presentation using this subgroup's transcriptional and clinical data. RESULTS: Among 363 gliomas-190 IDH-wildtype GBMs, 113 IDH-mutant astrocytomas, and 60 IDH-mutant oligodendrogliomas-the frequency of seizure as a presenting symptom was assessed. The rate of seizure presentation was significantly lower in IDH-wildtype GBM (30.5%) than in IDH-mutant astrocytoma (56.6%) and IDH-mutant oligodendroglioma (66.7%; p < 0.001) with no difference in seizure at recurrence among the groups. Seizure presentation was associated with smaller-volume tumors and less peritumoral edema in IDH-wildtype GBM (both p < 0.001) and with smaller-volume tumors in IDH-mutant astrocytoma (p = 0.0289). Seizure presentation had lower-grade tumors in IDH-mutant astrocytoma (p = 0.026). When accounting for relevant clinical factors, there was no survival difference between seizure at presentation and seizure at recurrence for any glioma subtype. Transcriptional analysis demonstrated upregulation of pathways related to ion transport and synaptic function in seizure-presenting IDH-wildtype tumors, including specifically IGFN1, RELN, and SLC17A8 (VGLUT3). VGLUT3, a vesicular glutamate transporter, was elevated at a protein level for IDH-wildtype GBM presenting with seizures. A multivariate logistic regression for seizure presentation combining clinical and transcriptional variables demonstrated that temporal location (p = 0.032, OR 3.25), parietal location (p = 0.023, OR 5.44), and SLC17A8 levels (p = 0.019, OR 3.44) were positively predictive of seizure, whereas the presence of edema (p = 0.004, OR -7.57) and ADAMTS2 expression (p = 0.015, OR -3.46) were both negative predictors. CONCLUSIONS: In IDH-wildtype GBM, tumors presenting with seizures had smaller volumes than those presenting with other signs. Transcriptionally, seizure presentation in IDH-wildtype GBM correlated with the upregulation of synaptic and ionic pathways, with SLC17A8 holding independent predictive value for seizure presentation.
引用
- McDonald MF, Athukuri P, Khan AB, et al. Seizure-presenting IDH-wildtype glioblastoma and the upregulation of a synaptic signature. J Neurosurg. 2026. PMID: 41962162. doi:10.3171/2025.11.JNS251412
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。